Plans

Short term plans

ACTIVITIES

Apr-Aug 2018

>Building the team (need critical mass)

Current members: Abvance Biotech, Eli Lilly, GSK, MedImmune, Novartis, 

Potential members: Pfizer, UCB pharma, BMS, Roche, Lonza

>Validating and refining the problem statements

>Clarifying and validation on the value proposition

>Scope definition

>Define our objectives

>Identify key risks (challenges)

>Compile list of questions, discussion topics, activities

Jun-Oct 2018

>Internal executive and legal sponsor engagement (approval and validation)

>Defined user & business requirements

EVENTS

27-28th Jun 2018

>EMBL-EBI workshop - Chris Lloyd and Richard Norman will present the project with a view to obtaining further buy-in

Oct 2018 (to coincide with Pistoia Alliance US conference in Boston?)

>F2F Project workshop - aim is to use this as a Kick-off for the delivery phase of the project